Regentis Biomaterials Ltd (RGNT)

$1.97 0.00 (N/A)
Market Cap 10.20M
Revenue (ttm) 0.00
Net Income (ttm) -13.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.25
Volume 15,900
Avg Vol 107,430
Day's Range N/A - N/A
Shares Out 5.18M
Stochastic %K 14%
Beta N/A
Analysts Strong Sell
Price Target $10.00

Company Profile

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 972 9 960 1917
Address:
60, Medinat Hayehudim, Entrance C Herzlia Pituach, Herzliya, Israel
NetworkNewsWire
NetworkNewsWire Sep. 2 at 8:03 PM
NetworkNewsBreaks – $RGNT GelrinC Advances Toward New Era of Regenerative Orthopedic Care https://nnw.fm/f1a8b
0 · Reply
wdcstocks
wdcstocks Sep. 2 at 3:46 PM
$RGNT New HOD 2.09
0 · Reply
wdcstocks
wdcstocks Aug. 31 at 7:58 PM
$RGNT new HOD 2.14
0 · Reply
wdcstocks
wdcstocks Aug. 31 at 7:56 PM
$RGNT new HOD 2.10
0 · Reply
wdcstocks
wdcstocks Aug. 31 at 2:40 PM
$RGNT New HOD 2.07
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 27 at 7:30 PM
Regenerative Hydrogel Is Redefining Cartilage Repair as Regentis Advances GelrinC $RGNT https://ibn.fm/fpuWW
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 27 at 7:23 PM
MissionIRNewsBreaks – $RGNT Expands GelrinC Clinical and Commercial Pathways https://ibn.fm/GnnIY
0 · Reply
tickldfunnybone
tickldfunnybone Aug. 22 at 6:40 PM
$RGNT crazy that this hasn't started climbing yet.
1 · Reply
Bullish_Swagger
Bullish_Swagger Aug. 21 at 10:11 PM
$RGNT - Bussin Bussin*
0 · Reply
TheeVoid
TheeVoid Aug. 21 at 9:58 PM
$RGNT $7.4M cash at year-end 2025.Z
0 · Reply
Latest News on RGNT
Regentis announces Japan Patent Office issued Notice of Allowance

2026-07-20T13:20:18.000Z - 6 weeks ago

Regentis announces Japan Patent Office issued Notice of Allowance

Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology

Jul 20, 2026, 9:00 AM EDT - 6 weeks ago

Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology

Regentis receives European regulatory approval for new GelrinC manufacturing

2026-07-15T13:20:47.000Z - 7 weeks ago

Regentis receives European regulatory approval for new GelrinC manufacturing

Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial Launch

Jul 15, 2026, 9:00 AM EDT - 7 weeks ago

Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial Launch

Regentis Biomaterials registers to sell 3.81M ordinary shares for holders

2026-07-08T20:35:26.000Z - 2 months ago

Regentis Biomaterials registers to sell 3.81M ordinary shares for holders

Regentis Biomaterials prices $6.5M private placement at $3.50 per share

2026-06-18T01:15:07.000Z - 2 months ago

Regentis Biomaterials prices $6.5M private placement at $3.50 per share

Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement

Jun 17, 2026, 9:05 PM EDT - 2 months ago

Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement

Regentis Biomaterials Ltd trading resumes

2026-06-17T14:40:08.000Z - 2 months ago

Regentis Biomaterials Ltd trading resumes

Regentis Biomaterials Ltd trading halted, volatility trading pause

2026-06-17T14:31:23.000Z - 2 months ago

Regentis Biomaterials Ltd trading halted, volatility trading pause

Why Is Regentis Biomaterials Stock (RGNT) Up Today?

2026-06-15T17:27:31.000Z - 2 months ago

Why Is Regentis Biomaterials Stock (RGNT) Up Today?

Regentis Biomaterials Ltd trading resumes

2026-06-15T16:25:07.000Z - 2 months ago

Regentis Biomaterials Ltd trading resumes

Regentis Biomaterials Ltd trading halted, news pending

2026-06-15T15:48:28.000Z - 2 months ago

Regentis Biomaterials Ltd trading halted, news pending

Regentis Biomaterials to commence European surgeon training for GelrinC

2026-06-08T12:41:04.000Z - 3 months ago

Regentis Biomaterials to commence European surgeon training for GelrinC

Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate

Jun 8, 2026, 8:32 AM EDT - 3 months ago

Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate

Regentis Biomaterials enters collaboration with Humanitas Research Hospital

2026-04-16T12:51:22.000Z - 4 months ago

Regentis Biomaterials enters collaboration with Humanitas Research Hospital

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon

Apr 16, 2026, 8:30 AM EDT - 4 months ago

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon

Regentis Biomaterials develops and patents solvent-free manufacturing process

2026-03-17T13:07:43.000Z - 5 months ago

Regentis Biomaterials develops and patents solvent-free manufacturing process

Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

Mar 17, 2026, 8:30 AM EDT - 5 months ago

Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

Regentis Biomaterials initiated with a Buy at ThinkEquity

2026-03-02T11:39:51.000Z - 6 months ago

Regentis Biomaterials initiated with a Buy at ThinkEquity

Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update

Feb 24, 2026, 4:15 PM EST - 6 months ago

Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update

Regentis Biomaterials appoints Galit Reke as CMO

2026-02-19T13:57:38.000Z - 6 months ago

Regentis Biomaterials appoints Galit Reke as CMO

Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair

Feb 19, 2026, 8:30 AM EST - 6 months ago

Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair

Regentis Biomaterials expands European clinical site network

2026-02-17T13:45:16.000Z - 6 months ago

Regentis Biomaterials expands European clinical site network

Regentis Biomaterials appoints Ori Gon as CFO, CBO

2026-02-04T14:01:34.000Z - 7 months ago

Regentis Biomaterials appoints Ori Gon as CFO, CBO

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial

Feb 4, 2026, 8:33 AM EST - 7 months ago

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial

Regentis Biomaterials expanding Phase III GelrinC clinical site network

2026-01-29T13:50:51.000Z - 7 months ago

Regentis Biomaterials expanding Phase III GelrinC clinical site network

Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

Jan 29, 2026, 8:33 AM EST - 7 months ago

Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

Regentis Biomaterials Ltd trading resumes

2026-01-28T16:25:13.000Z - 7 months ago

Regentis Biomaterials Ltd trading resumes

Regentis Biomaterials Ltd trading halted, volatility trading pause

2026-01-28T16:05:14.000Z - 7 months ago

Regentis Biomaterials Ltd trading halted, volatility trading pause

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

Jan 20, 2026, 8:33 AM EST - 7 months ago

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation

Jan 6, 2026, 8:21 AM EST - 8 months ago

Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation

Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC

Dec 18, 2025, 8:35 AM EST - 8 months ago

Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Dec 5, 2025, 4:10 PM EST - 9 months ago

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

Dec 3, 2025, 7:23 PM EST - 9 months ago

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

Israeli hydrogel implant developer Regentis Biomaterials files and sets terms for a $10 million US IPO

Mar 11, 2025, 9:16 AM EDT - 1 year ago

Israeli hydrogel implant developer Regentis Biomaterials files and sets terms for a $10 million US IPO

Regentis Biomaterials IPO Registration Document (F-1)

Mar 11, 2025, 6:09 AM EDT - 1 year ago

Regentis Biomaterials IPO Registration Document (F-1)

NetworkNewsWire
NetworkNewsWire Sep. 2 at 8:03 PM
NetworkNewsBreaks – $RGNT GelrinC Advances Toward New Era of Regenerative Orthopedic Care https://nnw.fm/f1a8b
0 · Reply
wdcstocks
wdcstocks Sep. 2 at 3:46 PM
$RGNT New HOD 2.09
0 · Reply
wdcstocks
wdcstocks Aug. 31 at 7:58 PM
$RGNT new HOD 2.14
0 · Reply
wdcstocks
wdcstocks Aug. 31 at 7:56 PM
$RGNT new HOD 2.10
0 · Reply
wdcstocks
wdcstocks Aug. 31 at 2:40 PM
$RGNT New HOD 2.07
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 27 at 7:30 PM
Regenerative Hydrogel Is Redefining Cartilage Repair as Regentis Advances GelrinC $RGNT https://ibn.fm/fpuWW
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 27 at 7:23 PM
MissionIRNewsBreaks – $RGNT Expands GelrinC Clinical and Commercial Pathways https://ibn.fm/GnnIY
0 · Reply
tickldfunnybone
tickldfunnybone Aug. 22 at 6:40 PM
$RGNT crazy that this hasn't started climbing yet.
1 · Reply
Bullish_Swagger
Bullish_Swagger Aug. 21 at 10:11 PM
$RGNT - Bussin Bussin*
0 · Reply
TheeVoid
TheeVoid Aug. 21 at 9:58 PM
$RGNT $7.4M cash at year-end 2025.Z
0 · Reply
tickldfunnybone
tickldfunnybone Aug. 19 at 8:56 PM
$RGNT holding until $10 tbh
0 · Reply
Tredin2
Tredin2 Aug. 19 at 7:00 PM
$RGNT Great if this could hold 🫥
0 · Reply
wdcstocks
wdcstocks Aug. 19 at 5:55 PM
$RGNT 136K volume
0 · Reply
Maylayed
Maylayed Aug. 19 at 5:54 PM
$RGNT $10 PT
0 · Reply
wdcstocks
wdcstocks Aug. 19 at 5:51 PM
$RGNT I think this is still early - no growth in watchers
0 · Reply
wdcstocks
wdcstocks Aug. 19 at 5:49 PM
$RGNT 100 K volume
0 · Reply
tickldfunnybone
tickldfunnybone Aug. 19 at 5:48 PM
$RGNT
0 · Reply
wdcstocks
wdcstocks Aug. 19 at 5:46 PM
$RGNT Getting some volume - now 66K
0 · Reply
wdcstocks
wdcstocks Aug. 19 at 5:46 PM
$RGNT new HOD 2.44
0 · Reply
tickldfunnybone
tickldfunnybone Aug. 19 at 5:44 PM
$RGNT is it go time?
0 · Reply
wdcstocks
wdcstocks Aug. 19 at 5:44 PM
$RGNT new HOD 2.35
0 · Reply
wdcstocks
wdcstocks Aug. 19 at 5:44 PM
$RGNT Let's go - New HOD 2.33
0 · Reply